Medicine
Systematic Review Methodology in Evidence-Based Urology
Quick fact
A systematic review does not automatically produce one high-confidence answer. It reduces avoidable bias through a predefined question, comprehensive search, duplicate study selection, risk-of-bias assessment and transparent synthesis; meta-analysis is optional.
Why this is interesting
Two trials of the same urology treatment can reach different conclusions. A systematic review can explain the disagreement, but only if its own decisions are transparent and rigorous.
Read the full explanation
Understanding Systematic Review Methodology in Evidence-Based Urology
Suppose researchers want to compare two treatments for kidney stones. They first define the question precisely: which patients, interventions, comparators and outcomes count? A protocol sets the eligibility and analysis rules before the results are known, reducing the temptation to change methods after seeing favourable findings. Reviewers search multiple databases and other relevant sources using a reproducible strategy, then screen records against the criteria. Ideally, more than one reviewer independently checks study selection and extracts data. The included studies are assessed for risks such as flawed randomisation, missing outcomes or selective reporting. Results can then be summarised narratively or, when studies are sufficiently comparable, combined statistically in a meta-analysis. Combining numbers is not always appropriate: different operations, patient groups or outcome definitions can make a pooled estimate misleading. The review must therefore report heterogeneity, uncertainty and limitations. Its conclusion can be strong, weak or genuinely inconclusive depending on the evidence found.
A deeper explanation
Systematic review methodology creates an auditable chain from a clinical question to a conclusion. A focused question is translated into eligibility criteria and a protocol, which can be registered or published. Information specialists and reviewers build searches broad enough to capture relevant evidence across bibliographic databases, trial registers and reference lists. Deduplication and documented screening produce a flow of included and excluded records. Data extraction records study design, participants, interventions, outcomes and numerical results, while a design-appropriate risk-of-bias tool evaluates how each result could be distorted. Synthesis comes next. A narrative synthesis may be the most honest choice when studies differ substantially. If meta-analysis is justified, the effect measure and statistical model must match the data, and reviewers examine heterogeneity, sensitivity to assumptions and possible missing evidence. Certainty frameworks can then distinguish a precise pooled number from confidence that the number is close to the truth. PRISMA 2020 is chiefly a reporting guideline: following its checklist makes methods and findings visible, but cannot rescue a poor search, biased studies or inappropriate analysis. Urology adds practical variation in surgeon experience, technique, devices and outcome definitions, so subgroup claims need particular caution. A useful review may establish benefit, reveal uncertainty or show that better trials are needed; it should never manufacture certainty merely by pooling studies.